VitaDAO's decentralized funding model and focus on early-stage longevity research align with Eniola's independent CCT model and DeSci platforms. However, the applicant's work targets addiction neuroscience rather than direct longevity, and the DAO's IP-NFT model may require adaptation for his pre-patent stage.